UNMC Rapid Autopsy Biorepository for Pancreatic and Prostate Cancer
Critical Resources Provided by UNMC RAP Biorepository Stimulate Cancer Research
This program collects high-quality tissue and fluid samples shortly after death from people with pancreatic or prostate cancer to help researchers develop better tests and treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Nebraska Medical Center NIH-funded |
| Lab location | 1 site (Omaha, United States) |
| Project ID | NIH-11177606 on NIH RePORTER |
What this research studies
From a patient's perspective, this program arranges rapid collection of organs, tumors, and body fluids within about five hours after death to preserve cells and molecules. The samples are processed, archived, and shared with approved researchers across the UNMC pancreatic and prostate cancer programs. It focuses on capturing specimens that represent many stages of disease so scientists can study real human tumors and their spread. The biorepository supports many lab projects and larger grants by making rare, well-preserved human material available.
Who could benefit from this research
Good fit: Ideal candidates are people with advanced pancreatic or prostate cancer who agree to post-mortem tissue donation and can make arrangements with the UNMC Rapid Autopsy Program.
Not a fit: People without pancreatic or prostate cancer, those who cannot provide consent for post-mortem donation, or those who die far from the collection site are unlikely to directly benefit from participating.
Why it matters
Potential benefit: If successful, this resource could speed discovery of new diagnostic markers and therapies by giving researchers better human tumor samples.
How similar studies have performed: Rapid autopsy programs at other cancer centers have produced valuable human specimens that led to new insights, so this approach is established though specialized.
Where this research is happening
Omaha, United States
- University of Nebraska Medical Center — Omaha, United States (Active)
Researchers
- Principal investigator: Grandgenett, Paul M — University of Nebraska Medical Center
- Study coordinator: Grandgenett, Paul M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.